Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Arizona Urology Specialists, Tucson, Arizona University of Florida, Gainesville, Florida Australia
Australian Prostate Center, Melbourne N., Victoria Epworth HealthCare, Melbourne N., Victoria